Celebrating 50 years of scientific
advancement –
learn more
Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
Moises Zanetti
Notice concerning the start of construction of a new drug product plant
by Moises Zanetti
JCR Pharmaceuticals proudly supports Rare Disease Day 2025
by Moises Zanetti
Notice of partial correction to “FY2024 third quarter consolidated financial results conference call material”
by Moises Zanetti
JCR Pharmaceuticals’ research presentations at WORLDSymposium 2025 showcase research from its investigational treatments for LSDs
by Moises Zanetti
FY2024 third quarter consolidated financial results conference call scrip
February 4, 2025
FY2024 third quarter consolidated financial results conference call material
by Moises Zanetti
Revision of consolidated financial forecasts for fiscal year ended March 31, 2025
by Moises Zanetti
Financial summary consolidated financial results for the nine months ended December 31, 2024 (FY2024) (Japanese standard)
by Moises Zanetti
1
…
4
5
6
Privacy Preference Center
Privacy Preferences
